论文部分内容阅读
2型糖尿病的发病与胰岛素抵抗和胰岛素分泌缺陷有关,瑞格列奈是最新一代非磺脲类快速作用促胰岛素分泌剂,与二甲双胍合用治疗2型糖尿病取得良效,现报告如下。
Type 2 diabetes is associated with insulin resistance and insulin secretion defects. Repaglinide is the latest generation of non-sulfonylurea fast-acting insulin secretagogues that has been shown to be effective with metformin in the treatment of type 2 diabetes.